Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Bevevino

Orthopaedic Surgery of the Spine Tucson, AZ Medical Doctor

NPI 1922260538 CMS profile 1288619

5301 E Grant Rd, Tucson, AZ 85712

Open in the dashboard

General payments

$17,916

89 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Bevevino of Tucson, AZ is reported in the CMS Open Payments database as having received $17,916 across 89 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 56th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,348 8
2024 General $8,199 26
2023 General $2,313 18
2022 General $4,678 19
2021 General $355 6
2020 General $858 8
2019 General $165 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Bevevino
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Adam Bevevino were reported at $1,348. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Adam Bevevino Orthopaedic Surgery of the Spine median Middle half National median
2019 $165 $2,106 $337–$18,608 $163
2020 $858 $1,213 $156–$15,082 $114
2021 $355 $1,834 $271–$15,617 $132
2022 $4,678 $2,015 $320–$17,036 $149
2023 $2,313 $1,925 $336–$14,599 $160
2024 $8,199 $2,110 $341–$12,483 $164
2025 $1,348 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $9,207 42 payments
  2. Alphatec Spine, Inc $2,675 8 payments
  3. Camber Spine Technologies $2,374 5 payments
  4. The Institute of Musculoskeletal Science and Education $1,316 4 payments
  5. NuVasive, Inc. $890 8 payments
  6. Orthofix Medical, Inc. $564 5 payments
  7. Kuros Biosciences USA, Inc $244 1 payment
  8. SI-BONE, Inc. $174 3 payments
  9. Stryker Corporation $147 2 payments
  10. Boston Scientific Corporation $123 1 payment
  11. Other $201 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $7,673 28 payments
  2. Consulting Fee $6,340 4 payments
  3. Food and Beverage $2,987 55 payments
  4. Royalty or License $916 2 payments
Products named General payments · program years 2019–2025
  1. O-ARM $6,045 8 payments
  2. Other - Miscellaneous $2,632 6 payments
  3. MAZOR X SYSTEM $1,405 13 payments
  4. XLIF $773 5 payments
  5. CLYDESDALE PTC SPINAL SYSTEM $626 3 payments
  6. Orthros $609 1 payment
  7. Lattus $515 3 payments
  8. Spira $307 1 payment
  9. MAGNETOS $244 1 payment
  10. UNID_PASS $224 3 payments
  11. Other $1,628 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

893

Median for Orthopedic Surgery: 203

Drug cost

$8,715

Median for Orthopedic Surgery: $1,433

Branded share of claims

14.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 237 $2,663
Methocarbamol Generic 211 $2,289
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 98 $797
Calcitonin-Salmon Calcitonin,salmon,synthetic Brand 11 $559
Meloxicam Generic 131 $501
Methylprednisolone Generic 55 $443
Cyclobenzaprine Hcl Generic 27 $298
Diclofenac Sodium Generic 13 $285
Pregabalin Generic 18 $227
Oxycodone Hcl Generic 22 $211

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 92 billing codes

Paid by Medicare

$190,021

Medicare's payments for the services billed

Medicare patients

520

Average age 75

Services billed

1,546

308 women, 212 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Ischemic heart disease 24%
Depression 24%
Osteoporosis 23%
Diabetes 21%
Chronic kidney disease 21%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record